🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a one-arm, open, multicenter phase 1b/2 clinical trial of YL-...
Status
Unknown
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2022-09-24
Trial ID
NCT05457517
Treatments Being Tested
YL-13027-001 is a phase I open-label, first in human, dose escalation study...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2019-03-19
Trial ID
NCT03869632
Treatments Being Tested
Part 1 (Phase Ia): This is a dose escalation, 3 + 3 design study, to evalu...
Status
Unknown
Location
MD Anderson Cancer Center
Start Date
2022-05-17
Trial ID
NCT05228600
Treatments Being Tested
To learn if the study drug, YL-13027, is safe to give in combination with g...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2024-01-22
Trial ID
NCT06199466
Treatments Being Tested
In Phase 1b study, six subjects will be enrolled in Arm A (YL-13027 + AG re...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-30
Trial ID
NCT06662669
Treatments Being Tested